HeartBeam Partners with Mount Sinai to Validate AI-Based 12-Lead ECG Algorithms
HeartBeam has launched a strategic collaboration with Mount Sinai to develop and validate AI-based 12-lead ECG algorithms for remote monitoring, including patient wellness insights and chronic condition assessments. The partnership supports HeartBeam’s cable-free, three-dimensional ECG platform and advances its AI-driven cardiac analysis capabilities.
1. Collaboration Established
On April 24, HeartBeam and Mount Sinai initiated a strategic collaboration to advance artificial intelligence-driven electrocardiogram solutions. The agreement commits both parties to jointly develop and clinically validate high-value AI-based ECG algorithms that can be integrated into HeartBeam’s diagnostic platform.
2. AI ECG Algorithm Development
The collaboration will focus on creating AI models that deliver patient-relevant wellness insights, condition-focused assessments, and tools for chronic cardiac condition management. These algorithms are designed to enhance remote monitoring capabilities and provide actionable cardiac intelligence outside traditional healthcare settings.
3. Cable-Free 12-Lead ECG Platform
HeartBeam’s core technology is a cable-free, three-dimensional 12-lead ECG system capable of capturing comprehensive heart electrical signals in portable devices. The company holds 17 issued patents across key markets and aims to deploy its AI-enabled platform broadly to redefine cardiac health monitoring.